posted June 27, 2022 03:15 pm by jelliedeeel
(11)
Definitely Morgan Stanley pumping it up. I would love to know what the strategy is. Last record high was MS buying and they were selling on the way down as well.
rate and reply
posted June 27, 2022 02:12 pm by Qccity1
(28)
Anonymous and Morgan Stanley have switched on the Buying side! Better volume than the last weeks and a good increase. Q3 results in 2 -3 weeks. It smells good! GLTA!
rate and reply
posted June 10, 2022 10:15 am by bossu
(229)
TAVR procedure benefits a larger group of patients and with the minimalist approach growing in popularity within the medical community, the benefits of the SavvyWire could be significant."
...read more
posted June 10, 2022 07:03 am by Lesalpes29
(803)
Last this, If I’m not wrong Mr. Villeneuve only Have 25k options to exercise at 1.33.
rate and reply
posted June 10, 2022 06:54 am by retiredcf
(8753)
Pretty impressive during another tough day in the markets. GLTA Symbol/ Company Price $ Change $ Volume Data delayed at least 15 minutes,
...read more
posted June 10, 2022 06:45 am by Lesalpes29
(803)
Robin Villeneuve exercised options without selling any this Week. Robin Villeneuve did many transactions since one month or more. Exercised ar 1.33 And sold on open market right after. But not this
...read more
posted June 09, 2022 02:17 pm by ivebeenthere
(87)
Hopefully we finish with a bang!
rate and reply
posted June 08, 2022 12:28 pm by ddogold
(347)
The Fall is shaping up to be transformational for us . GLTA
rate and reply
posted June 08, 2022 09:09 am by jelliedeeel
(11)
Here's the press release dating back to September 3rd 2015 relating to the corporate restructuring I was referring to in my previous post: https://opsens.com/2015/opsens-announces-a-reorganization
...read more
posted June 08, 2022 08:53 am by jelliedeeel
(11)
Dogs, either you're short and a bit worried so you try to keep the stock down or you didn't do your research properly ...or both. Opsens reorganised in 2015 to seperate physically and
...read more
posted June 07, 2022 07:41 pm by Dogsbreakfast4U
(281)
Edwards Lifescience per example could be interested in Opsens Medical but couldn't care less about Opsens Solutions which is why I doubt Opsens the company will be a take over target.
rate and reply
posted June 07, 2022 04:40 pm by bossu
(229)
Opsens to be a take over target not long after FDA approval... The TAVR procedure is on the rise, driven by an aging of the population and recent studies that demonstrate its benefits to patients of
...read more
posted June 07, 2022 04:00 pm by ivebeenthere
(87)
The last month was very tough for investors but in the same period Opsens is up 30%. In about 5 weeks the results of the third quarter will come out and i think those will be very good. glta
rate and reply
posted June 07, 2022 01:00 pm by Dogsbreakfast4U
(281)
FDA approval is now expected in the Fall. Initially they had said late Summer or Fall.
rate and reply
posted June 07, 2022 10:10 am by Possibleidiot01
(1052)
Key word - significant ! Timeline reiterated. . As the TAVR procedure benefits a larger group of patients and with the minimalist approach growing in popularity within the medical community, the
...read more
posted June 02, 2022 12:46 pm by ivebeenthere
(87)
As of today i am in the money l hope im not alone and the stock does not deflate again. Goog luck to all
rate and reply
posted June 02, 2022 10:55 am by Qccity1
(28)
As soon as OPS gets some momentum, MS is trying to push it down with 100 shares blocks... I continue to think they try to maintain a reasonable price, waiting for next quarter's results and FDA
...read more
posted May 26, 2022 12:32 pm by Possibleidiot01
(1052)
OpSens is now very undervalued, says Raymond James By Geordie Carragher Published on May 22, 2022 Last Updated on May 22, 2022 Filed under: All posts, Analysts, Health
...read more